Clinical Trial Update: Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SHR-A1811 to physician's choice in colorectal cancer patients who progressed after oxaliplatin, 5-FU, and irinotecan; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Colorectal Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING